Stanford’s Multidisciplinary Cutaneous and T-Cell Lymphoma Program (MCTLP)

As a model of interdisciplinary scientific collaboration and community partnership, Stanford’s Multidisciplinary Cutaneous and T-Cell Lymphoma Program (MCTLP) is improving the lives of patients with rare cancers. In one diagnostic and treatment area after another, Stanford has led the world with its vision of precision medicine for patients who suffer the devastating impacts of cutaneous lymphoma, a unique subset of non-Hodgkin’s lymphoma. The video above provides window into the unparalleled growth and development of a global scientific community, featuring patient stories and a track record of breakthroughs leading to a novel effort to develop a first-in-class personalized immunotherapy vaccine. Take a look at the unparalleled growth and development of a global scientific community laser focused on tackling this orphan disease. Hear from patients, clinicians, and researchers about how novel discoveries and breakthroughs are leading to the development of personalized immunotherapy vaccines that for the first time may offer lasting relief.